Fount of Information

Novus社 Tipping the Scale for Improved Immunotherapies

この製品に関するご意見・ご照会・お問合せはこちら

logo.png

OUR BRANDS: R&D SYSTEMS  NOVUS BIOLOGICALS  TOCRIS BIOSCIENCE  PROTEINSIMPLE  ACD  EXOSOME 

Improving_Immune_System_Response.png

 

The immune system has a potent anti-tumor response, and the tumor has a potent anti-immune response. Discover how researchers are helping to tip the scale in favor of the anti-tumor immune response.

 

Learn_more.PNG

 


Live Webinar Exploiting.png

Live Webinar Exploiting Tumor Hypoxia for Targeted Immunotherapy

Can targeting tumor hypoxia improve immunotherapy? 

 

In the complex landscape of the tumor microenvironment (TME), hypoxia is a common feature as tumor growth often outpaces the blood supply. In our upcoming live webinar learn more about the complex relationship between hypoxia and T cells within the TME and strategies to improve immunotherapy.

 

Join_us.PNG

 

Nominate_today.png


 

The_Natural_NK_Cell_Army.jpg

The Natural NK Cell Army

NK cells are the emerging cell type for cancer immunotherapies, including chimeric antigen receptor (CAR)-NK cell therapies. Our blog shares perspective on their unique properties and their role in anti-tumor immunotherapy.

 

Find_out_more.PNG

Fount of Information は、新商品、新規取扱メーカーなどの情報をいち早く紹介するコンテンツです。情報発信のスピードを重視しているコンテンツのため、現時点で法規制や取り扱いを確認できていない商品、定価を設定できていない商品があります。ご要望やご照会を受けた商品について、法令整備や在庫の充実を図ります。